🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration

RecruitingNAAges 18 Years - anyAllUniversidad de Murcia
NCT03997552 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Three techniques for periodontal reconstruction will be compared, in which marginal access versus apical access will be carried out.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients diagnosed with periodontitis. * plaque index and bleeding index of \< 30%. * periodontal lesions with pocket probing depth \> 5 mm. * intrabony defect \> 3 mm. * intrabony defect configuration including a 1 and/or 2-wall component, always involving the buccal wall. Exclusion Criteria: * patients with systemic diseases that contraindicated treatment. * third molars. * teeth with incorrect endodontic or restorative treatment.
💊

What it tests

  • Non-incised papillae surgical approach (NIPSA)
  • marginal approach by palatal incision
  • Minimally invasive surgical technique (MIST)
📍

Where

1 site
Centro Odontologico Del Sureste Slp
Murcia, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy